DAFNEGIN 6 OV VAG 100MG

DAFNEGIN

active ingredients

A 100 mg vaginal ovum contains: cyclopyroxolamine 0.100 g. 100 g vaginal cream contain: cyclopyroxolamine 1 g.

Excellent

A 100 mg vaginal ovum contains: benzoic acid, glycerylmonoricinoleate, semisynthetic glycerides. 100 g vaginal cream contain: 2-ottildodecanol, liquid paraffin, spinning vaseline, cetilic alcohol, stearilic alcohol, myristilic alcohol, dietnolamide of coconut fatty acids, polysorbate 60, monostearate sorbitan, benzilic alcohol, lactic acid, deionized water.

Therapeutic indications

Vaginal eggs: vulvo-vaginal affections produced by Candida. Vaginal cream: vulvo-vaginal and peri-anali affections produced by Candida.

Contraindications

Individual hypersensitivity ascertained towards the drug.

Population

Vaginal eggs: 1 ovum of 100 mg for 3-6 days depending on the severity of the infection and in judgement of the doctor.Vaginal cream: screw the applicator on the cream tube and fill it by doing a slight pressure on the tube. Introduce the applicator deep into the vagina and apply the content (g 5) daily before bed for 6 consecutive days or, according to the doctor, up to a maximum of 14 days. For the application it is recommended a position on the back with the legs slightly bent. To prevent a reinfection it is appropriate to treat with a little vaginal cream also skin peri-vaginal and peri-anale.

Conservation

No special precaution: normal storage conditions at room temperature.

Warnings

A mutual infection is possible; to prevent a re-infection, it is advisable to have the partner's therapy. In topical or intravaginal applications there is virtually no systemic absorption of the preparation. The use, especially if prolonged, of drugs for topical use can give rise to phenomena of sensitization. In this case it is necessary to suspend treatment and to take appropriate therapeutic measures.

Interactions

They're not known.

Effects

Rarely itching, burning or local irritation. Dafnegin, vaginal cream, contains among the excipient cetilic alcohol and stearilic alcohol as basic components. This should be taken into account in the case of hypersensitivity known to these substances.

Overdosing

Given the pharmacological characteristics, there are no overdose risks.

In pregnancy the drug should be administered in cases of actual need and under the direct control of the doctor.

Source: Farmadati